Table 2.
r | P value | |
---|---|---|
Age (Yr) | 0.092 | NS |
BMI (kg/m2) | 0.066 | NS |
Plt (104/μL) | −0.172 | NS |
Albumin (g/dL) | −0.252 | <0.001 |
T-bil (mg/dL) | 0.071 | NS |
AST (IU/L) | 0.196 | NS |
ALT (IU/L) | −0.019 | NS |
ChE (U/L) | −0.284 | <0.001 |
γ-GTP (IU/L) | 0.165 | NS |
AFP (ng/mL) | 0.188 | NS |
TG (mg/dL) | −0.113 | <0.05 |
LDL-C (mg/dL) | 0.087 | NS |
HDL-C (mg/dL) | −0.136 | NS |
HbA1c (%) | 0.035 | NS |
FBS (mg/dL) | 0.009 | NS |
IRI (μIU/L) | 0.178 | NS |
HOMA-IR | 0.130 | NS |
cCK18 (U/L) | 0.121 | NS |
M2BPGi (COI) | 0.415 | <0.001 |
FIB4 index | 0.268 | <0.01 |
APRI | 0.236 | NS |
Pathological findings | ||
Steatosis (0/1/2/3) | −0.012 | NS |
Lobular inflammation (0/1/2/3) | 0.314 | <0.01 |
Ballooning (0/1/2) | 0.285 | <0.01 |
Fibrosis (0/1/2/3/4) | 0.292 | <0.001 |
The relationship between AAT-A3F and clinicopathological parameters was analysed using Spearman’s R correlations.